Ohcanbohtosat - Cuilian Guo

  • Čájehuvvo 1 - 3 / 3
Aiddostahte ozu
  1. 1
    Bearbmagovva

    Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System Dahkki Huqun Li, Cuilian Guo, Chongshu Wang

    Almmustuhtton 2024
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Bearbmagovva

    Post-marketing safety of lorlatinib: a real-world study based on the FDA adverse event reporting system Dahkki Huqun Li, Chongshu Wang, Cuilian Guo

    Almmustuhtton 2024
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Bearbmagovva

    A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system Dahkki Huqun Li, Chongshu Wang, Aiping Deng, Cuilian Guo

    Almmustuhtton 2023
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: